2014-2015 Basic and Clinical Science Course (BCSC): Section by American Academy of Ophthalmology, Eric P. Purdy

By American Academy of Ophthalmology, Eric P. Purdy

Covers systemic health conditions probably to impact ophthalmic sufferers, similar to infectious, metabolic, neurologic and cardiovascular illnesses; melanoma; and rheumatic and endocrine issues. features a dialogue of preventive drugs and clinical emergencies, geriatrics and facts. Ophthalmic issues are highlighted all through. includes references and tables directory the names, symptoms and negative effects of antibiotic, antihypertensive and anticancer drugs.

Upon finishing touch of part 1, readers could be capable to:

Describe the ophthalmic manifestations of significant systemic diseases
Summarize the key disorder procedures affecting many of the grownup inhabitants, and in short clarify how preventive measures could lessen the morbidity and mortality they cause
List many of the elements linked to a patient's compliance or noncompliance with scientific regimens

Show description

Read or Download 2014-2015 Basic and Clinical Science Course (BCSC): Section 1: Update on General Medicine PDF

Best ophthalmology books

Complications in Ophthalmic Plastic Surgery

This multi-contributed textual content intends to fill a void in ophthalmic literature by means of having a look into eyelid and lacrimal surgical procedure problems and their respective remedies. A extensive variety of ophthalmologists, together with citizens and normal ophthalmologists, will enjoy the direct and concise assurance of the main more often than not encountered methods.

Curbside consultation in pediatric GI : 49 clinical questions

Are you trying to find concise, useful solutions to these questions which are frequently left unanswered by way of conventional pediatric GI references? Are you looking short, evidence-based suggestion for classy circumstances or arguable judgements? Curbside session in Pediatric GI: forty nine medical Questions offers speedy solutions to the tough questions most typically posed in the course of a “curbside session” among pediatricians.

Extra resources for 2014-2015 Basic and Clinical Science Course (BCSC): Section 1: Update on General Medicine

Example text

Tuberculosis Tuberculosis (TB) infection usually occurs through inhalation of infective droplets and, in rare cases, by way of the skin or gastrointestinal tract. Cell-mediated hypersensitivity to tuberculoprotein develops 3-9 weeks after infection, with a typical granulomatous response that slows or contains bacterial multiplication. Most organisms die during the fibrotic phase of the response. Reactivation is usually associated with depressed immunity and aging. Systemic spread occurs with reactivation and results in a granulomatous response to the infected foci.

Infect Dis Clin North Am. 2008;22(2):341-360. Chlamydia trachomatis Members of Chlamydia trachomatis are small, obligate, intracellular parasites that contain DNA and RNA and have a unique biphasic life cycle. These prokaryotes use the host cell's CHAPTER 1: Infectious Disease • 17 energy-generating capacity for their own reproduction. C trachomatis can survive only briefly outside the body. Transmitted by close contact, it is the most common sexually transmitted infection, with 4 million new cases per year.

It is now clear that this disorder is caused by a direct infection of renal cells by HIV. The CDC has classified HIV infection into the 3 stages outlined in Table 1-3. The older categories A, B, and C of HIV infection are now designated as stages 1, 2, and 3, respectively. Stage 1 HIV infection is defined by either CD4+ T-lymphocyte count of more 30 • Update on General Medicine Table 1-3 Surveillance Case Definition for Human Immunodeficiency Virus (HIV) Infection Among Adults and Adolescents (aged ~13 Years)-United States, 2008 Stage Laboratory Evidence* Clinical Evidence Stage 1 Laboratory confirmation of HIV infection and CD4+ T-lymphocyte count of 2500 cells/µL or CD4+ T-lymphocyte percentage of 229 Laboratory confirmation of HIV infection and CD4+ T-lymphocyte count of 200-499 cells/µL or CD4+ T-lymphocyte percentage of 14-28 Laboratory confirmation of HIV infection and CD4+ T-lymphocyte count of <200 cells/µL or CD4+ T-lymphocyte percentage of <14t Laboratory confirmation of HIV infection and no information on CD4+ T-lymphocyte count or percentage None required (but no AIDSdefining condition) Stage 2 Stage 3 (AIDS) Stage unknown§ None required (but no AIDSdefining condition) or documentation of an AIDSdefining condition (with laboratory confirmation of HIV infection)t and no information on presence of AIDS-defining conditions *The CD4+ T-lymphocyte percentage is the percentage of total lymphocytes.

Download PDF sample

Rated 4.69 of 5 – based on 7 votes